NIH-funded research U01 cooperative agreement

Identifying protein markers to understand and predict pancreatic cancer risk

Official title: Uncovering Causal Protein Markers to Characterize Pancreatic Cancer Etiology and Improve Risk Prediction

Funded at University of Hawaii at Manoa · NIH-10946247 · Data updated 2026-11-12

This study is looking at how certain proteins might contribute to pancreatic cancer, with the goal of helping patients understand their risk better and improving ways to detect the disease early.

More Pancreatic Cancer research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Hawaii at Manoa
NIH-funded
Lab location1 site (Honolulu, United States)
Project startSeptember 18, 2024
Project endAugust 31, 2029
Funding year2024
Award (this year)$737,444
NIH project number1U01CA293883-01
Project IDNIH-10946247 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals at high risk for pancreatic cancer, such as those with a family history of the disease or specific genetic predispositions.

Less likely to help

Patients with non-cancerous conditions or those without risk factors for pancreatic cancer may not receive any benefit from this research.

What this research studies

This research focuses on pancreatic cancer, particularly pancreatic ductal adenocarcinoma, which is a leading cause of cancer death. It aims to uncover the causal role of specific proteins in the development of this cancer and improve risk prediction models. By utilizing advanced methodologies, including genetic instruments, the study seeks to address inconsistencies in previous findings related to protein biomarkers. Patients may benefit from enhanced screening strategies and better understanding of their risk factors for pancreatic cancer.

Why it matters

Potential benefit: If successful, this research could lead to more accurate risk assessments and improved screening methods for pancreatic cancer.

How similar studies have gone: Previous research has shown promise in identifying protein biomarkers for various cancers, suggesting that this approach could yield valuable insights for pancreatic cancer as well.

Where this research is happening

  • University of Hawaii at Manoa
    Honolulu, United States
    Active

Researchers

  • Principal investigator: Wu, Lang — University of Hawaii at Manoa
  • Study coordinator: Wu, Lang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.